Pfizer To Go Ex-Dividend On May 9th, 2025 With 0.43 USD Dividend Per Share
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
Pfizer Options Spot-On: On May 7th, 106.28K Contracts Were Traded, With 3.48 Million Open Interest
Jim Cramer on Pfizer (PFE): "Trying Big Targets, but New Wins Still Elusive"
Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says -- Barrons.com
Pfizer, J&J, Genentech Drugs Subject of FDA Advisory Panel Meeting This Month
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Argus Research Maintains Pfizer(PFE.US) With Hold Rating
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers
Pfizer Options Spot-On: On May 6th, 196.49K Contracts Were Traded, With 3.44 Million Open Interest
Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
Trump Administration Cancels Meeting With FDA Workers Union - Report
Express News | Shares of Vaccine and Gene Therapy Stocks Are Trading Lower After FDA Commissioner Marty Makary Reportedly Named Vinay Prasad as Director of the Center for Biologics and Research
Express News | 'FDA Names Vinay Prasad as New Head of Vaccines, Biologics'- Bloomberg Law
Express News | Moderna Falls 12%, Pfizer Falls 3.3% and Novavax Falls 6.3%
FDA Plans to Increase Surprise Inspections at Overseas Manufacturing Sites
10 Health Care Stocks With Whale Alerts In Today's Session